Fluvastatin: efficacy and safety in reducing cardiac events

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.11, 2005-09, pp. : 1883-1895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvastatin viable option for preventing cardiac events

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Fluvastatin viable option for preventing cardiac events

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Comparison of the Efficacy, Safety and Tolerability of Policosanol versus Fluvastatin in Elderly Hypercholesterolaemic Women

By Fernández J.C.

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 103-113

Adis International

Access to resources Recommend Favorite

Fluvastatin: Clinical and Safety Profile

By Corsini A.

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1305-1323

Adis International

Access to resources Recommend Favorite

An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK

By Scuffham P.A. Chaplin S.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 525-535

Adis International

Access to resources Recommend Favorite